ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Egile nagusia: | R.T. Saygitov |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
"Paediatrician" Publishers LLC
2008-08-01
|
Saila: | Вопросы современной педиатрии |
Sarrera elektronikoa: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Antzeko izenburuak
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
nork: R.T. Saygitov
Argitaratua: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
nork: Cardile S, et al.
Argitaratua: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
nork: Yu. V. Yevsyutina
Argitaratua: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
nork: Gold Benjamin D, et al.
Argitaratua: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
nork: Roy C Orlando, et al.
Argitaratua: (2010-09-01)